Diabetes and other metabolic disorders

Published on 02/03/2015 by admin

Filed under Internal Medicine

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1576 times

17 Diabetes and other metabolic disorders

Introduction

The study of metabolism (Box 17.1) began as long ago as the fifteenth century bc, with the first description of diabetes in the Ebers Papyrus. Metabolic diseases comprise a variety of disorders encompassing a number of medical specialties. They contribute significantly to mortality and morbidity, predominantly from cardiovascular disease. Diabetes and metabolic disorders have become more prevalent in both developed and developing countries, leading to a significant burden of chronic disease and complications related to those diseases. This increased prevalence is related to excessive calorific intake coupled with reduced physical activity. Whereas in the past metabolic diseases such as diabetes were deemed diseases of the rich, in developed countries they are now frequently diseases of lower social class, as access to healthier foods may be expensive and difficult.

The major metabolic disorders considered in this chapter are:

Diabetes mellitus and the metabolic syndrome

Diabetes is a Greek word meaning ‘a passer through; a siphon’, and mellitus derives from the Greek word for ‘sweet’. The Greeks named it thus due to the excessive amounts of urine produced by sufferers which attracted insects because of its glucose content. The ancient Chinese tested for diabetes by observing whether ants were attracted to a person’s urine.

Diabetes mellitus is the most common metabolic disorder encountered in clinical practice. It is strongly linked to obesity. Diabetes mellitus is characterized by abnormal carbohydrate and lipid homoeostasis, leading to elevation in plasma glucose, or hyperglycaemia, and abnormality of serum lipids, or dyslipidaemia. Glucose homoeostasis is modulated mainly by the release of insulin from the islet cells (β cells) of the pancreas. Diabetes develops as a result of a variable combination of absolute insulin deficiency as a result of pancreatic islet cell dysfunction and tissue insulin resistance due to reduced cellular responsiveness to insulin.

The World Health Organization (WHO) has developed a classification of diabetes mellitus based on its pathogenesis (Table 17.1). The two predominant classes of diabetes are type 1 and type 2, and clinical differences between the two are listed in Table 17.2. Type 1 is characterized by absolute insulin deficiency due to autoimmune-mediated pancreatic islet cell destruction. In contrast, type 2 diabetes is associated with a variable degree of tissue insulin resistance, leading – at least in the early stages – to high plasma insulin levels, then subsequently to relative insulin deficiency as pancreatic islet cell function fails to overcome this resistance. The diagnostic criteria for disorders of glucose metabolism based on the 75-g oral glucose tolerance test are shown in Table 17.3. Note that glycosuria itself (glucose in the urine) is not a reliable diagnostic test for diabetes mellitus.

Table 17.1 The World Health Organization classification of diabetes mellitus

Type Common subtypes/pathogenesis Treatment
Type 1 Destruction of pancreatic islet cells leading to insulin deficiency Insulin
Type 2 Ranges from predominantly insulin resistance with relative insulin deficiency (often associated with obesity) to predominantly insulin deficiency Diet/oral hypoglycaemic agents/insulin
Other types
Genetic defects of β-cell function Diabetes associated with glucokinase, hepatic nuclear factor (HNF) 1α, HNF1β, HNF4α, Neurod1 and insulin promotor factor mutations (all previously grouped under maturity-onset diabetes of the young (MODY))
Mitochondrial diabetes
Tablets or insulin depending upon genetic defect
Genetic defects of insulin action Insulin-resistance syndromes (type A insulin resistance, leprechaunism, Rabson-Mendenhall syndrome lipoatrophic diabetes) Insulin-sensitizing agents and insulin
Diseases of the exocrine pancreas Fibrocalculous pancreatic diabetes, pancreatitis, trauma/pancreatectomy, neoplasia, cystic fibrosis, haemochromatosis, others Frequently insulin required
Endocrinopathies Cushing’s syndrome, acromegaly, phaeochromocytoma, glucagonoma, hyperthyroidism, somatostatinoma, others Treatment of underlying cause
Drug or chemical induced Glucocorticoids, α-adrenergic agonists, β-adrenergic agonists, thiazides, interferon-α therapy Avoid
Uncommon forms of immune-mediated diabetes Insulin autoimmune syndrome (antibodies to insulin), anti-insulin receptor antibodies, ‘stiff man’ syndrome Variable
Other genetic syndromes associated with diabetes Down’s, Friedreich’s ataxia, Huntington’s chorea, Klinefelter’s, Lawrence-Moon-Biedl, myotonic dystrophy, porphyria, Prader-Willi, Turner’s, Wolfram’s Variable
Gestational diabetes   Diet/insulin

Table 17.2 Clinical differences between type 1 and type 2 diabetes

  Type 1 Type 2
Ketosis prone Yes Uncommon
Insulin requirement Yes (absolute insulin deficiency) Often later in disease (insulin resistance ± deficiency)
Onset of symptoms Acute Often insidious
Obese Uncommon Common
Age at onset (years) Usually <30 Usually >30
Family history of diabetes 10% 30%
Concordance in monozygotic twins 30-50% 90-100%

It has long been recognized that many people have a clustering of risk factors for cardiovascular disease. Thus, the term metabolic syndrome has been coined, with various pseudonyms of syndrome X or insulin resistance syndrome. Clinical and biochemical characteristics of the metabolic syndrome are shown in Box 17.2. People with the syndrome are at high risk of diabetes and cardiovascular disease. The condition is common among certain ethnic groups (African-Americans, Mexican-Americans, Asian Indians, Australian Aboriginals), and features can be present for up to 10 years before hyperglycaemia is detected. Vigorous treatment can reduce mortality and morbidity from cardiovascular disease.

Presenting symptoms of diabetes

Many people with type 2 diabetes may be asymptomatic at diagnosis, for example by routine screening of blood or urine, when there may be only mildly increased levels of hyperglycaemia. Once diagnosed, however, many patients do admit to some longstanding, often mild symptoms. Acute metabolic decompensation, leading to marked hyperglycaemia, occurs infrequently.

In contrast, type 1 diabetes is often abrupt in onset, and characterized by severe hyperglycaemia with acute life-threatening decompensation (diabetic ketoacidosis).

The cardinal symptoms of diabetes mellitus are weight loss, polyuria and polydipsia, and their presence should always result in an immediate test for blood glucose and urine for ketones.

Polyuria, polydipsia and nocturia

Acute hyperglycaemia causes increased urine excretion (polyuria) and, as a result, excessive thirst and water ingestion (polydipsia). These presenting symptoms of diabetes mellitus are also termed osmotic symptoms. Raised plasma glucose leads to increased renal tubular delivery of glucose, which then exceeds the resorptive capacity of the renal tubule, leading to glycosuria. Therefore, despite hyperglycaemia, people with an increased renal threshold for glucose may have no osmotic symptoms. Conversely, people with a low renal threshold for glucose may have glycosuria despite being normoglycaemic. It is for this reason that glycosuria is an unreliable feature in the diagnosis of diabetes mellitus. Nocturia is also common in patients presenting with osmotic symptoms of diabetes, and enquiry regarding the frequency of passing urine at night can be helpful in evaluating symptoms.

Other conditions can cause polyuria and polydipsia (Table 17.4). Diabetes insipidus (DI) is characterized by loss of renal concentrating capacity, owing to either loss of secretion of antidiuretic hormone (arginine vasopressin) from the posterior pituitary gland (cranial DI) or to poor renal tubular responsiveness to antidiuretic hormone (nephrogenic DI). This leads to loss of free water which, if uncorrected by increased water ingestion, can lead to severe dehydration and plasma hypertonicity. Electrolyte disturbance, such as hypercalcaemia or hypokalaemia, can impair antidiuretic hormone action and hence lead to polyuria and polydipsia. In addition, polyuria and nocturia are common symptoms of chronic renal failure.

Table 17.4 Causes of polyuria

Osmotic diuresis Diabetes mellitus, chronic renal failure, drugs
Polydipsia Psychogenic
Lack of antidiuretic hormone (ADH) Cranial diabetes insipidus due to: idiopathic, surgery, pituitary/hypothalamic tumour, familial, postpartum
Failure of response to ADH Nephrogenic diabetes insipidus due to: primary, renal tubular disorders, hypokalaemia, hypercalcaemia, drugs

Other important aspects of a diabetic history

Symptoms of complications of diabetes

Chronic complications of diabetes mellitus can be usefully subdivided into large blood vessels (macrovascular), small blood vessels (microvascular) and others (Table 17.5).

Table 17.5 Chronic complications of diabetes

Macrovascular Coronary heart disease
Peripheral vascular disease
Cerebrovascular disease
 
Microvascular Retinopathy

Neuropathy Nephropathy   Other Dermatological Rheumatological Hepatic

Symptoms of macrovascular disease

The features of ischaemic heart disease are described elsewhere (see Ch. 11). People with diabetes have fewer, less severe symptomatic chest pains, possibly due to autonomic neuropathy leading to reduced deep pain sensation – so-called silent ischaemia. Thus, the only symptom of ischaemic heart disease in a diabetic subject may be breathlessness.

Peripheral vascular disease presents with claudication (Ch. 11). In addition, in patients with diabetes, a combination of peripheral neuropathy and peripheral vascular disease can lead to foot ulceration, particularly at sites of pressure (Fig. 17.2).

Cerebrovascular disease in diabetic patients can present with any stroke syndrome (Ch. 14). Transient ischaemic attacks are common.

Symptoms of microvascular disease

Diabetic retinopathy is frequently asymptomatic until it causes significant visual loss, which may be acute in onset (e.g. owing to a sudden retinal haemorrhage) or insidious (e.g. owing to cataract or maculopathy). Diabetic nephropathy is similarly asymptomatic until renal dysfunction becomes so severe that uraemia ensues (see Ch. 18). Uraemic symptoms include fatigue, breathlessness and tachypnoea, pleuritic chest pain due to pericarditis and pruritus. Heavy proteinuria may lead to the development of a nephrotic syndrome.

In contrast, diabetic neuropathy can manifest in a number of ways. Chronic peripheral sensory neuropathy is the commonest form, affecting around 5% of patients with diabetes. This can present with symptoms varying from numbness, a feeling of ‘walking on cotton wool’ and paraesthesiae (pins and needles) to burning, sharp and shooting pains. The latter is a feature of selective involvement of small pain fibres. Typically the symptoms start distally and spread up in a stocking distribution, and are characteristically worse at night, frequently leading to insomnia.

Proximal motor neuropathy (diabetic amyotrophy, or femoral neuropathy) is uncommon, but is seen predominantly in middle-aged men with type 2 diabetes. The condition is characterized by severe, deep pain and paraesthesiae in the upper anterior thigh, followed by weakness and wasting of the quadriceps muscle. The condition is often unilateral, generally short-lived (around 3 months) and usually resolves spontaneously. Associated weight loss and cachexia are common.

Mononeuropathies, particularly affecting the median nerve of the hand (carpal tunnel syndrome; see Ch. 14) are common in patients with diabetes. This frequently presents with paraesthesiae and numbness in the median nerve distribution of the hand (lateral two-and-half digits) and is again worse at night. Similar symptoms may occur in the foot (tarsal tunnel syndrome). Cranial mononeuropathies are rare, but palsies of cranial nerves III, VI and VII are seen in patients with diabetes, leading to blurred or double vision due to ophthalmoplegia, or a lower motor neurone facial palsy (Ch. 14). The pupillomotor fibres are usually spared in diabetic third nerve palsy.

Diabetes can cause autonomic neuropathy, the symptoms of which can be very troublesome. They include impotence, gustatory sweating (severe facial sweating on tasting food), urinary retention or incontinence, dizziness or syncope due to postural hypotension, constipation or diarrhoea (so called diabetic diarrhoea) and recurrent nausea and vomiting due to diabetic gastroparesis.

Examination of the diabetic patient

General assessment

Patients with diabetes can present with acute metabolic decompensation, leading to diabetic ketoacidosis (DKA), hyperosmolar hyperglycaemic syndrome (HHS) or, in treated patients, hypoglycaemia. Thus, it is mandatory for all patients presenting with coma or reduced conscious level to have their blood glucose checked immediately.

Characteristically, the cardinal symptoms of severe polyuria, polydipsia and weight loss will have been present for some time prior to coma; such symptoms should never be ignored in a diabetic person. Patients with acute hyperglycaemic crises are frequently severely dehydrated, with hypotension (including postural hypotension), tachycardia, dry mucous membranes and reduced skin turgor. Other signs of DKA include rapid deep sighing respiration (Kussmaul breathing – a respiratory compensation for metabolic acidosis) and ketones on the breath (a sweet odour reminiscent of nail polish remover). Diabetic ketoacidosis can occasionally present with symptoms of an acute abdomen.

In the non-acute setting, measurement of weight and height to ascertain the body mass index (BMI) is of great importance in the assessment of the diabetic patient (Box 17.3). It is desirable for all patients with diabetes to undergo a full medical assessment once a year – the so-called diabetic annual review (Box 17.4).

Skin, nails and hands

Dermatological manifestations of diabetes are common. Fungal nail infections, particularly of the feet, are common, as are dermatophyte infections of the skin of the feet (tinea pedis). Staphylococcal skin infections leading to pustules, abscesses or carbuncles can also be seen. Other skins lesions seen in diabetes include necrobiosis lipoidica diabeticorum (Fig. 17.3). This is a rare complication of diabetes, predominantly seen in young women aged 15-40 years. This presents as a painless red macule, usually over the anterior shin, which then heals with scarring to form a yellowish/brown lesion. The condition can be unsightly, and little effective treatment is available. Vitiligo is seen in a small number of patients with type 1 diabetes, reflecting its autoimmune nature.

Diabetic dermopathy is characterized by brown macules on the lower legs that heal to form atrophic, shiny white scars. A further skin lesion seen in patients with diabetes is granuloma annulare, pale, shiny rings and nodules usually seen on the hands (Fig. 17.4). Bullosis diabeticorum is a rare manifestation, characterized by tense blistering, mainly on the feet. Acanthosis nigricans is characterized by a dark velvety appearance in the axillae or neck of people with insulin resistance (Fig. 17.5) and frequently accompanies type 2 diabetes, but may occur in people with insulin resistance in the absence of diabetes.

image

Figure 17.4 Granuloma annulare.

(Courtesy of Dr David Peterson.)

Diabetic patients treated with insulin should have their injection sites examined for signs of lipohypertrophy (a physiological response to insulin injected near fat cells) (Fig. 17.6) or lipoatrophy (an allergic response to non-human insulins – now rarely seen) (Fig. 17.7).

image

Figure 17.6 Lipohypertrophy.

(Courtesy of Dr David Peterson.)

image

Figure 17.7 Lipoatrophy.

(Courtesy of Dr David Peterson.)

Diabetic cheiroarthropathy, or ‘stiff hand syndrome’ or ‘limited joint mobility’, is seen in some patients with longstanding diabetes. It is characterized by skin thickening and sclerosis of the tendon sheaths, leading to reduced joint mobility and the characteristic prayer sign (Fig. 17.8). Examination of the hands for signs of carpal tunnel syndrome (Ch. 14) is important if the patient has suggestive symptoms. Thus, the presence of Tinel’s sign (Fig. 17.9) and Phalen’s sign (Fig. 17.10) should be sought. Thenar eminence wasting may also be seen.

Eyes

Examination of the eyes is mandatory in patients with diabetes. External examination may indicate signs of dyslipidaemia (corneal arcus and xanthelasmata; Fig. 17.11). A reduced pupillary response to light may indicate autonomic neuropathy. Visual acuity should be assessed yearly with a Snellen chart, and unexplained loss of acuity should be investigated. Funduscopy should be undertaken with pharmacological dilatation of the pupils in order to obtain an adequate view. Loss of the red reflex on funduscopy may indicate cataract formation, and the lens should be assessed for opacities (Fig. 17.12). The vitreous and retina should be examined carefully, starting from the optic disc and radiating into each quadrant of the eye. The macula is examined last, as this can be quite uncomfortable for the patient. The use of green light may aid the detection of microaneurysms. Ideally, all patients with diabetes should have annual fundal photography. A classification of diabetic retinopathy is shown in Box 17.5 (and see Figs 17.1317.17).

image

Figure 17.17 Exudative diabetic maculopathy.

(Courtesy of Dr Paul Dodson.)

Feet

The feet of patients with diabetes should be examined at least once a year. Signs of deformity, callus (a sign of excessive pressure at this site), fungal infection especially between the toes, nail care and ulceration should be carefully assessed. Peripheral pulses and nail-fold refill should be assessed for signs of peripheral vascular disease. Nerve function should be assessed by testing vibration sense at the great toe, medial malleolus and knee, and testing fine touch on the toes, metatarsal heads, heels and dorsum of the feet with a 10-g monofilament (Semmes Weinstein monofilament) (Fig. 17.18). Loss of ankle jerks is also a sign of early diabetic peripheral sensory neuropathy.

A complication of diabetic peripheral neuropathy is the neuropathic joint – Charcot neuroarthropathy (see Fig. 17.2). This usually affects the ankle and presents with a painless, swollen, hot red joint, sometimes with a history of minor local trauma. The natural history is of progressive deformity until the process settles, usually over a few months. Untreated, the joint develops severe deformity, which then puts the foot at high risk of ulceration, infection and amputation. Treatment is with immobilization in a plaster-cast boot, and intravenous bisphosphonates.

Diabetic patients with signs of peripheral vascular disease or peripheral neuropathy, even if asymptomatic, should be classified as at high risk for ulceration and be given careful education on foot care by a podiatrist.

Investigation

Diagnosis of diabetes is based on a fasting plasma glucose or oral glucose tolerance test (OGTT), using the WHO criteria (see Table 17.3). Although clinically it is relatively simple to distinguish between type 1 and type 2 diabetes, occasionally the diagnosis is not clear, especially in younger-onset type 2 diabetes without a family history. In these circumstances, the use of immunological tests such as anti-islet cell (ICA) or antiglutamic acid decarboxylase (GAD) antibody may be helpful. Positivity of either is a good indicator of autoimmune islet cell destruction (and hence probable type 1 diabetes), insulin deficiency and a subsequent requirement for insulin therapy.

In acute hyperglycaemic decompensation of diabetes, urgent investigations are required, including a laboratory glucose estimation, assessment of renal function (urea and electrolytes), urinalysis testing for ketones and glucose, and arterial blood gas assessment to determine pH and bicarbonate level. A search for precipitating causes should be undertaken, including a chest radiograph, ECG, white cell count and, in younger women, a pregnancy test.

In order to reduce the risk of chronic complications, it is important to ensure a full biochemical assessment is undertaken yearly as part of an annual diabetic review. Renal and liver function should be checked, along with assessment of urine albumin excretion. Glycaemic control can be assessed using the glycated haemoglobin (HbA1c), which is well correlated to prevailing glycaemic control over the preceding 10-12 weeks. Glycaemic targets are individualized according to the patient’s age, comorbidities, risk of hypoglycaemia and his own preferences. An HbA1c less than 7.0% (53 mmol/mol) is generally deemed to show acceptable glycaemic control. There is some suggestion that HbA1c may be useful for diagnosis of diabetes, with a level above 6.5% (48 mmol/mol) being recommended for diagnosis of diabetes by the American Diabetes Association. At the time of writing, however, the International Diabetes Federation has not yet recommended this change. Lipid profile (cholesterol, triglycerides, low-density lipoprotein (LDL) cholesterol and high-density lipoprotein (HDL) cholesterol) should be checked yearly.

Lipid disorders

The two circulating lipids, cholesterol and triglyceride, are transported within lipoproteins in the circulation. The apolipoproteins over the surface of these molecules enable their recognition by cells in organs such as the liver. The different types of lipoprotein are shown in Table 17.6.

Table 17.6 Types of lipoprotein

Lipoprotein Apolipoprotein Characteristics
Chylomicrons Apo B48 Mainly triglyceride containing
Apo E Manufactured by gut wall
Apo C-II Metabolized in liver/cells by lipoprotein lipase
Very low density (VLDL) Apo B100 Main carrier of triglycerides in circulation
Apo E Metabolized by lipoprotein lipase to IDL
Intermediate density (IDL)   VLDL remnants which are removed by liver
Low density (LDL) Apo B100 Main carrier of cholesterol in circulation
50% of circulating LDL is removed by liver each day
Small dense LDL highly atherogenic
Direct correlation of serum LDL levels with coronary heart disease (CHD)
High density (HDL) Apo A1 Transports 30% of total circulating cholesterol
Inverse correlation of serum HDL levels with CHD

Lipid disorders are common and contribute significantly to the burden of cardiovascular disease. They can be conveniently divided into primary and secondary (Table 17.7). Primary lipid disorders are usually inherited, whereas secondary are acquired as a result of other medical disorders.

History

Lipid disorders rarely cause significant symptoms, unless the patient presents with an acute feature such as acute pancreatitis or myocardial infarction. Thus, any previous history of vascular disease or acute abdominal pain should be sought. Acute pancreatitis is a rare complication of severe hypertriglyceridaemia, and presents with acute severe generalized abdominal pain. Although alcohol and cholelithiasis are the commonest causes of acute pancreatitis, hypertriglyceridaemia is a well recognized and easily overlooked cause of the condition, and any patient presenting with acute pancreatitis should have his serum lipids checked.

In the assessment of patients with lipid disorder, it is important to enquire about symptoms of ischaemic heart disease (chest pain history, admissions for ischaemic heart disease and any cardiological/cardiothoracic interventions), peripheral vascular disease (intermittent claudication) and cerebrovascular disease (transient ischaemic attacks, amaurosis fugax and strokes). Other cardiovascular risk factors should also be assessed. The smoking history is very important and a family history of premature vascular disease (under the age of 55 years) should be carefully sought. In familial hypercholesterolaemia, half of men and a fifth of women die before the age of 60 from coronary heart disease. Possible symptoms of secondary causes should also be assessed. Thus, symptoms of hypothyroidism (Ch. 16), diabetes (above), renal failure or nephrotic syndrome (Ch. 18) and liver disease (Ch. 12) should be sought. Alcohol intake and dietary history should also be assessed.

Diagnostic criteria for familial hypercholesterolaemia are shown in Box 17.6.

Examination

The diagnostic hallmark of familial hypercholesterolaemia is tendon xanthomata. These are localized infiltrates of lipid-containing macrophages that resemble atherosclerotic plaques; they develop from the third decade onwards. The commonest sites are the Achilles tendon and the extensor tendons of the hands, particularly over the knuckles (Fig. 17.19). Other sites include the tibial tuberosities, at the site of insertion of the patellar tendon (subperiosteal xanthomata) or at the triceps tendon at the elbow.

image

Figure 17.19 Tendon xanthoma of the hands.

(Courtesy of Dr David Peterson.)

As the cholesterol deposition is deep within the tendon, and the swelling is fibrous, tendon xanthomata are felt as hard nodules along the length of the tendon. They occasionally become inflamed, and a tenosynovitis develops. On the extensor surface of the hands, they may overlie the knuckle and be very hard and quite easy to miss.

Xanthelasmata are deposits of lipid in the skin of the eyelids, more commonly the upper rather than the lower (see Fig. 17.11). Although a dramatic sign, they are not present in the majority of patients with familial hypercholesterolaemia. More common is a corneal arcus, seen as a rim of lipid deposit around the iris (Fig. 17.11). This can be seen at any age, although it is more common in older people; only in the minority is this sign associated with hypercholesterolaemia.

The characteristic sign of hypertriglyceridaemia is eruptive xanthomata (Fig. 17.20). These are yellow nodules or papules that usually appear on the extensor surface of the elbows, knees, buttocks and back. Striate palmar xanthomas are yellowish discoloration of the skin creases, usually seen best in the hands, and are due to hypertriglyceridaemia. In severe forms of hypertriglyceridaemia, hepatosplenomegaly may be seen. Funduscopy in severe hypertriglyceridaemia may show lipaemia retinalis, characterized by optic pallor and the retinal vessels appearing white (Fig. 17.21).

image

Figure 17.21 Lipaemia retinalis.

(Courtesy of Dr Paul Dodson.)

A careful cardiovascular examination should be performed in all patients with significant hyperlipidaemia, including a search for carotid or femoral bruits and signs of peripheral vascular disease. Patients with homozygous familial hypercholesterolaemia may have signs of aortic stenosis.